Delivery Order SPE2DR25D6028-SPE2DR26FASMA
Award Date 12/8/25
Potential Completion Date 12/9/25
Potential Value $6.6K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $84,852.28 on December 24, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30s. This competitively awarded, firm fixed-price contract carries an ultimate completion date of December 26, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. The delivery order was issued without a set-aside designation, indicating open competition among...
- The Defense Logistics Agency awarded a $6,558.42 firm fixed-price delivery order to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on December 8, 2025, with completion targeted for December 9, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The work will be performed at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for RINVOQ ER 15 mg tablets in a quantity of 30 units, with a ceiling value of $17,417.68. This firm fixed-price delivery order, which has no set-aside designation, is set to be completed by December 9, 2025, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. RINVOQ is a pharmaceutical product used in the treatment of inflammatory conditions,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) valued at $12,074.99. This is a firm fixed price, non-set-aside competitive delivery order with an ultimate completion date of November 19, 2025, and performance at the vendor's Conshohocken, Pennsylvania facility. This delivery order is a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with...
- The Defense Logistics Agency awarded a $123,569.74 firm fixed price delivery order to AmerisourceBergen Drug Corp for the supply of RINVOQ ER 15 mg tablets (30-count units) on December 10, 2025, with completion scheduled for December 11, 2025. This is a competitively awarded, non-set-aside delivery order with performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $16,372.33 for RINVOQ ER 15 mg tablets (30-count units) on December 19, 2025, with an ultimate completion date of December 22, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The order will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 28, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units) with a ceiling value of $40,502.39. This firm fixed-price delivery order, with an ultimate completion date of October 29, 2025, represents a non-competitive, non-set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency awarded a $39,149.39 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count units). This is a non-set-aside, competitively awarded contract with an ultimate completion date of December 30, 2025, and performance to be executed from the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a $10,035.14 delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of RINVOQ ER 15 mg tablets in quantities of 30 units. This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of December 30, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a competitively-awarded delivery order to AmerisourceBergen Drug Corp on November 24, 2025, for the supply of RINVOQ ER 15 mg tablets (30-count unit dose) valued at $11,788.91. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 global pharmaceutical support vehicle running through December 2026. The product will be delivered to the...